Drug Price Control?

Should there be any control on how much a drug company can charge for a medicine?

You’ve likely heard about this cove, Martin Shkreli, 32 year old former hedge fund manager whose company (Turing Pharmaceuticals) bought the rights to Daraprim (a drug that’s been around for 60 years and is the principal treatment for toxoplasmosis in people with immune deficiencies such as AIDS). They then raised the price from $13.50 to $750 per tablet.

There was an outcry. But there are many other instances where medicines, that are essential to keeping people alive, are subject to massive price hikes or frantically expensive from the get go.

In Canada and many European countries prices are capped. Why not in the US?

Can you afford them?

No Comments Yet.

Leave a comment